 Connection
Alok Singh to Antitubercular Agents
This is a "connection" page, showing publications Alok Singh has written about Antitubercular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.165 |
|
|
|
-
Singh AK, Yadav P, Karaulia P, Singh VK, Gupta P, Puttrevu SK, Chauhan S, Bhatta RS, Tadigoppula N, Gupta UD, Chopra S, Dasgupta A. Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis. Future Microbiol. 2017 11; 12:1349-1362.
Score: 0.490
-
Singh AK, Karaulia P, Yadav P, Narender T, Singh SP, Sashidhara KV, Pandey AK, Chopra S, Dasgupta A. Identification of lipid metabolism-targeting compounds active against drug-resistant M. tuberculosis. J Glob Antimicrob Resist. 2016 12; 7:26-27.
Score: 0.452
-
Singh M, Sarhan MO, Damiba NNL, Singh AK, Villabona-Rueda A, Nino-Meza OJ, Chen X, Masias-Leon Y, Ruiz-Gonzalez CE, Ordonez AA, D'Alessio FR, Aboagye EO, Carroll LS, Jain SK. Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis. Nat Commun. 2025 Mar 27; 16(1):3003.
Score: 0.205
-
Kumar A, Singh AK, Badole CM, Patond KR. Tubercular epidural abscess in children: report of two cases. Indian J Tuberc. 2009 Oct; 56(4):217-9.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|